Xiaodong Fang

Xiaodong Fang

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4407659
武田薬品工業株式会社
person_outline Xiaodong Fang's MOST POPULAR ARTICLES
1-) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAC Elden, HJ Kim, MP Hart, AS Chen-Plotkin, BS Johnson, X Fang, ...Nature 466 (7310), 1069-1075, 201012282010
2-) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLSZ Sun, Z Diaz, X Fang, MP Hart, A Chesi, J Shorter, AD GitlerPLoS biology 9 (4), e1000614, 20114672011
3-) Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease modelsM Armakola, MJ Higgins, MD Figley, SJ Barmada, EA Scarborough, ...Nature genetics 44 (12), 1302-1309, 20122352012
4-) Biphasic targeting and cleavage furrow ingression directed by the tail of a myosin IIX Fang, J Luo, R Nishihama, C Wloka, C Dravis, M Travaglia, M Iwase, ...Journal of Cell Biology 191 (7), 1333-1350, 20101362010
5-) The role of the Parkinson\'s disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeastA Chesi, A Kilaru, X Fang, AA Cooper, AD GitlerPloS one 7 (3), e34178, 2012672012